FTRE
Fortrea (FTRE)
NASDAQ
$16.41+$0.85 (+5.43%)
Price as of Jun 23, 2026 5:15 PM EDT
  • $1.5B
    Market Cap
  • 205.10%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
Income Statement
Total Operating Revenue
2.7B
+1.00%
2.7B
-13.27%
3.1B
N/A
Cost of Revenue
2.2B
+2.65%
2.2B
-16.47%
2.6B
N/A
Gross Profit
503.8M
-5.69%
534.2M
+2.65%
520.4M
N/A
Sales and Marketing Expense
456.4M
-18.60%
560.7M
+66.58%
336.6M
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
78.0M
-10.24%
86.9M
-9.85%
96.4M
N/A
Total Operating Expenses
3.6B
+25.81%
2.9B
-6.16%
3.0B
N/A
Operating Profit
-872.6M
+438.97%
-161.9M
-356.58%
63.1M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-91.4M
-26.17%
-123.8M
+77.36%
-69.8M
N/A
Interest Income and Expense and Net
-91.4M
-26.17%
-123.8M
+77.36%
-69.8M
N/A
Total Nonoperating Income and Expense
7.9M
-62.91%
21.3M
+208.70%
6.9M
N/A
Income before Taxes
-983.0M
+257.45%
-275.0M
-25,100.00%
1.1M
N/A
Income Taxes
3.2M
+191.43%
-3.5M
-177.78%
4.5M
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-986.2M
+200.21%
-328.5M
+9,561.76%
-3.4M
N/A
Net Income from Continuing Operations Applicable to Common
-986.2M
+263.24%
-271.5M
-24,781.82%
1.1M
N/A
Basic EPS and Net Income
-10.81
+194.55%
-3.67
+9,075.00%
-0.04
N/A
Diluted EPS and Net Income
-10.81
+194.55%
-3.67
+9,075.00%
-0.04
N/A
Basic Weighted Average Shares
91.2M
+1.90%
89.5M
+0.79%
88.8M
N/A
Diluted Weighted Average Shares
91.2M
+1.90%
89.5M
+0.79%
88.8M
N/A
Balance Sheet
Cash and Cash Equivalents
174.6M
+47.34%
118.5M
+9.12%
108.6M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
174.6M
+47.34%
118.5M
+9.12%
108.6M
N/A
Total Current Assets
897.2M
-5.38%
948.2M
-24.33%
1.3B
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
149.5M
-4.35%
156.3M
-29.24%
220.9M
N/A
Total Long-Term Assets
80.8M
-21.86%
103.4M
+30.06%
79.5M
N/A
Total Assets
2.7B
-24.13%
3.6B
-17.86%
4.4B
N/A
Income Taxes Payable
59.0M
+11.95%
52.7M
-14.86%
61.9M
N/A
Total Short-Term Debt
4.8M
-93.58%
74.8M
+186.59%
26.1M
N/A
Total Current Liabilities
913.3M
-3.81%
949.5M
+22.37%
775.9M
N/A
Total Long-Term Debt
1.0B
-0.16%
1.0B
-32.97%
1.6B
N/A
Total Long-Term Liabilities
39.3M
+11.33%
35.3M
-42.41%
61.3M
N/A
Total Liabilities
2.2B
-2.91%
2.2B
-15.34%
2.6B
N/A
Retained Earnings
-1.4B
+248.41%
-397.0M
+708.55%
-49.1M
N/A
Total Stockholders Equity
563.5M
-58.64%
1.4B
-21.65%
1.7B
N/A
Total Shares Outstanding
93.1M
+3.79%
89.7M
+1.01%
88.8M
N/A
Cash Flow
Cash from Operating Activities
113.5M
-56.81%
262.8M
+56.99%
167.4M
N/A
Capital Expenditures
25.2M
-1.18%
25.5M
-36.72%
40.3M
N/A
Cash from Investing Activities
14.4M
-94.28%
251.6M
+891.19%
-31.8M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
-76.3M
-84.67%
-497.8M
+258.13%
-139.0M
N/A
Financials Ratio
Gross Margin
18.50%
-6.63%
19.81%
N/A
N/A
N/A
Operating Margin
-32.04%
+433.63%
-6.00%
N/A
N/A
N/A
Return on Assets
-31.33%
+278.50%
-8.28%
N/A
N/A
N/A
Return on Equity
-102.41%
+383.42%
-21.19%
N/A
N/A
N/A
Revenue Growth
1.00%
+107.54%
-13.27%
N/A
N/A
N/A
Current Ratio
0.98
-1.62%
1.00
N/A
N/A
N/A
Cash Ratio
0.19
+53.21%
0.12
N/A
N/A
N/A
Debt-to-Equity Ratio
1.87
+126.35%
0.83
N/A
N/A
N/A
Debt-to-Assets Ratio
0.39
+23.39%
0.31
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow